<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001944053</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Shares, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/05/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001610853</issuerCik>
        <issuerName>HELIUS MEDICAL TECHNOLOGIES, INC.</issuerName>
        <issuerCusip>42328V884</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>642 NEWTOWN YARDLEY ROAD</com:street1>
          <com:city>NEWTOWN</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>18940</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Leonite Fund I, LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>163055.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>163055.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>163055.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.2</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Geller Avi</reportingPersonName>
      <citizenshipOrOrganization>NJ</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>163055.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>163055.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>163055.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.2</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>HELIUS MEDICAL TECHNOLOGIES, INC.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>642 NEWTOWN YARDLEY ROAD, NEWTOWN, NEW YORK, 18940</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule is being jointly filed by Leonite Fund I LP ("Leonite"), a Delaware limited partnership, and Avi Geller, an  individual (each a "Reporting Person" and together, the "Reporting Persons"). </filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business address of each Reporting Person is 600 East Crescent Avenue, STE 104, Upper Saddle River, NJ 07458.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Leonite is a Delaware limited liability company;
Mr. Geller is a citizen of the United States of America (state of New Jersey).</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Leonite is the record owner of 163,055 shares of common stock of the Issuer.  Mr. Geller is the chief investment officer of Leonite and has sole voting and dispositive power over the shares held by it.  As a result, Mr. Geller may be deemed to be an indirect beneficial owner of the shares held directly by Leonite.  Mr. Geller disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. </amountBeneficiallyOwned>
        <classPercent>The 163,055 shares of common stock represent approximately 5.19% of the Issuer's outstanding shares of common stock based on 3,140,166 shares of Common Stock outstanding (excluding the Common Stock underlying the Warrants).</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>163,055</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>163,055</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Leonite Fund I, LP</reportingPersonName>
      <signatureDetails>
        <signature>Avi Geller</signature>
        <title>Chief Investment Officer</title>
        <date>06/09/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Geller Avi</reportingPersonName>
      <signatureDetails>
        <signature>Avi Geller</signature>
        <title>an individual</title>
        <date>06/09/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
